Manufacture of 150 GN of cgmp PTH-IA
Ended Awarded Last action
- Contract number
- 75N95022F00001
- Awardee
-
Bachem Americas Inc. UEI ULM6JMNK5L83
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $597,350
Award facts
- Contract value 100% obligated
- $597,350.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Torrance, CA 90505, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $65,130 | |
| Supplemental Agreement for work within scope | $22,013 | |
| Original award | $510,207 |
About this award
The National Institutes of Health National Center for Advancing Translational Sciences awarded Bachem Americas, Inc. a $597,350 firm fixed price delivery order contract under the prime vendor's master indefinite-delivery/indefinite-quantity contract for Clinical Research Organization Support. The order is for Bachem Americas, Inc. to manufacture 150 grams of cGMP Parathyroid Hormone-related Protein type 1A in support of the funding agency's drug substance development and manufacture programs. Performance will occur at Bachem Americas, Inc.'s location in Torrance, California over a four year period concluding in March 2026.
Quick answers
Who was awarded contract 75N95022F00001?
75N95022F00001 was awarded to Bachem Americas Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 29, 2022.
How much is contract 75N95022F00001 worth?
The government has obligated $597,350 on 75N95022F00001.
Which agency awarded contract 75N95022F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95022F00001 an order under another contract?
Yes. 75N95022F00001 is a delivery order under HHSN271201700009I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract 75N95022F00001 competed?
The extent of competition for 75N95022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award